Archives of Neuroscience
Image Credit:Arch Neurosci
Do Cognitive Enhancers Have the Potential to Change the Structure of Harm Reduction in the Future?
Abstract
Footnotes
References
- 1.Dhavale TR, Varadharajulu G, Kanase SB. Current Physiotherapy Interventions For Higher Mental Function In Traumatic Brain Injury: Systematic Review. Educational Administration: Theory Practice. 2024;30(4).
- 2.Nesbit MO, Ahn S, Zou H, Floresco SB, Phillips AG. Potentiation of prefrontal cortex dopamine function by the novel cognitive enhancer d-govadine. Neuropharmacol. 2024;246:109849. [PubMed ID: 38244888]. https://doi.org/10.1016/j.neuropharm.2024.109849.
- 3.Martinez-Pernia D, Gonzalez-Castan O, Huepe D. From ancient Greece to the cognitive revolution: A comprehensive view of physical rehabilitation sciences. Physiother Theory Pract. 2017;33(2):89-102. [PubMed ID: 28071974]. https://doi.org/10.1080/09593985.2016.1266720.
- 4.Bostrom N, Sandberg A. Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics. 2009;15(3):311-41. [PubMed ID: 19543814]. https://doi.org/10.1007/s11948-009-9142-5.
- 5.Malik M, Tlustos P. Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers. Plants (Basel). 2023;12(6). [PubMed ID: 36987052]. [PubMed Central ID: PMC10056569]. https://doi.org/10.3390/plants12061364.
- 6.Wolpin J. The New Generation of Performance Enhancement: The Use and Regulation of Cognitive Enhancers. 2009. Available from: https://dash.harvard.edu/bitstream/handle/1/8822192/Wolpin%2C%20Joseph%20-200%20Course%20Paper.pdf?sequence=1&isAllowed=y.
- 7.Shailja C, Isha K, Shifali T, Hemlata K, Gitika C. Brahmi (Bacopa Monnieri)– a Potential Ayurvedic Cognitive Enhancer and Neuroprotective Herb. Int J Ayurveda Pharma Res. 2021;9(5):41-9. https://doi.org/10.47070/ijapr.v9i5.1917.
- 8.Walker EA, Pellegrini MV. Bacopa monnieri. Treasure Island (FL); 2024.
- 9.Rudra P. Ethical Underpinning and Implications of “Nootropic” Concept. Acta Universitatis Lodziensis. Folia Philosophica. Ethica-Aesthetica-Practica. 2018;(32):31-45. https://doi.org/10.18778/0208-6107.32.03.
- 10.Liao Z, Cheng L, Li X, Zhang M, Wang S, Huo R. Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease. Clin Neuropharmacol. 2020;43(4):93-9. [PubMed ID: 32658034]. https://doi.org/10.1097/WNF.0000000000000394.
- 11.Farooqui AA, Farooqui T, Madan A, Ong JH, Ong WY. Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects. Evid Based Complement Alternat Med. 2018;2018:2481076. [PubMed ID: 29861767]. [PubMed Central ID: PMC5976976]. https://doi.org/10.1155/2018/2481076.
- 12.Mahamid H, Nissim C. Sufis and Coffee Consumption. J Sufi Stud. 2018;7(1-2):140-64. https://doi.org/10.1163/22105956-12341311.
- 13.Phillips B. The Book of Herbs: An Illustrated AZ of the World's Most Popular Culinary and Medicinal Plants. Springville, UT: Cedar fort publishing & media; 2023.
- 14.Berihun G, Alemu K. Status of coffee leaf rust (Hemileia vastatrix) and its management in Ethiopia: a review. Arch Phytopathol Plant Protection. 2023;55(20):1-18.
- 15.Daly Guris RJ, Elliott EM, Doshi A, Singh D, Widmeier K, Deutsch ES, et al. Systems-focused simulation to prepare for COVID-19 intraoperative emergencies. Paediatr Anaesth. 2020;30(8):947-50. [PubMed ID: 32683765]. [PubMed Central ID: PMC7404905]. https://doi.org/10.1111/pan.13971.
- 16.Cappelletti S, Piacentino D, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015;13(1):71-88. [PubMed ID: 26074744]. [PubMed Central ID: PMC4462044]. https://doi.org/10.2174/1570159X13666141210215655.
- 17.Petersen RC. Cocaine: an overview. Drug Enforcement. 1977;4:9. https://doi.org/10.1037/e497202006-003.
- 18.Sayali C, Barrett FS. The costs and benefits of psychedelics on cognition and mood. Neuron. 2023;111(5):614-30. [PubMed ID: 36681076]. https://doi.org/10.1016/j.neuron.2022.12.031.
- 19.Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, et al. Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms. Mol Psychiatry. 2024;2024:1-14. https://doi.org/10.1101/2023.12.12.571374.
- 20.Allen J, Dames SS, Foldi CJ, Shultz SR. Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential. Mol Psychiatry. 2024;29(3):671-85. [PubMed ID: 38177350]. https://doi.org/10.1038/s41380-023-02360-0.
- 21.Dresler M, Sandberg A, Bublitz C, Ohla K, Trenado C, Mroczko-Wasowicz A, et al. Hacking the Brain: Dimensions of Cognitive Enhancement. ACS Chem Neurosci. 2019;10(3):1137-48. [PubMed ID: 30550256]. [PubMed Central ID: PMC6429408]. https://doi.org/10.1021/acschemneuro.8b00571.
- 22.Sharif S, Guirguis A, Fergus S, Schifano F. The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review. Brain Sci. 2021;11(3). [PubMed ID: 33802176]. [PubMed Central ID: PMC8000838]. https://doi.org/10.3390/brainsci11030355.
- 23.Racine E, Sattler S, Boehlen W. Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior. Sci Eng Ethics. 2021;27(2):19. [PubMed ID: 33759032]. [PubMed Central ID: PMC7987623]. https://doi.org/10.1007/s11948-021-00294-w.
- 24.Ragan CI, Bard I, Singh I; Independent Scientific Committee on Drugs. What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacol. 2013;64:588-95. [PubMed ID: 22732441]. https://doi.org/10.1016/j.neuropharm.2012.06.016.
- 25.Sharif S, Fergus S, Guirguis A, Smeeton N, Schifano F. Assessing prevalence, knowledge and use of cognitive enhancers among university students in the United Arab Emirates: A quantitative study. PLoS One. 2022;17(1). e0262704. [PubMed ID: 35081158]. [PubMed Central ID: PMC8791475]. https://doi.org/10.1371/journal.pone.0262704.
- 26.Naderi S, Charkhgard N, Rad P, Jafari S, Niknejad S. Changing Harm Reduction Approaches Is Not a Choice; It Is Necessary to Survive. Int J High Risk Behav Addiction. 2023;12(3). https://doi.org/10.5812/ijhrba-139609.
- 27.Brunyé TT, Brou R, Doty TJ, Gregory FD, Hussey EK, Lieberman HR, et al. A Review of US Army Research Contributing to Cognitive Enhancement in Military Contexts. J Cognitive Enhancement. 2020;4(4):453-68. https://doi.org/10.1007/s41465-020-00167-3.
- 28.Glavonic E, Mitic M, Adzic M. Hallucinogenic drugs and their potential for treating fear-related disorders: Through the lens of fear extinction. J Neurosci Res. 2022;100(4):947-69. [PubMed ID: 35165930]. https://doi.org/10.1002/jnr.25017.
Copyright
Copyright © 2024, Charkhgard et al. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Cognitive Psychopathology of Bipolar Disorder: Future Directions for Treatment
Cammisuli DM, Pruneti C. Cognitive Psychopathology of Bipolar Disorder: Future Directions for Treatment. Iran J Psychiatry Behav Sci. 2018;12(1):e9881. doi: https://doi.org/10.5812/ijpbs.9881
The Use of Cognitive Enhancers Among Medical Students
Mousavi F, Shojaei P, Pourgholami Markeh H. The Use of Cognitive Enhancers Among Medical Students. Int J High Risk Behav Addict. 2019;8(2):e92377. doi: https://doi.org/10.5812/ijhrba.92377
Horizons of Psychiatric Genetics and Epigenetics: Where Are We and Where Are We Heading?
Mostafavi Abdolmaleky H. Horizons of Psychiatric Genetics and Epigenetics: Where Are We and Where Are We Heading?. Iran J Psychiatry Behav Sci. 2014;8(3):. doi:
Selection of Person of the Year from Public Health Perspective: Promotion of Mass Clusters of Copycat Self-immolation
Zarghami M. Selection of Person of the Year from Public Health Perspective: Promotion of Mass Clusters of Copycat Self-immolation. Iran J Psychiatry Behav Sci. 2012;6(1):. doi:
Changing Harm Reduction Approaches Is Not a Choice; It Is Necessary to Survive
Naderi S, Charkhgard N, Rad P, Jafari S, Niknejad S. Changing Harm Reduction Approaches Is Not a Choice; It Is Necessary to Survive. Int J High Risk Behav Addict. 2023;12(3):e139609. doi: https://doi.org/10.5812/ijhrba-139609
Crossmark
Checking
- Scopus by DOI: 0
Last Update: 6 days ago
- Scopus by Title: 0
Last Update: 6 days ago
- Scopus by Title (Ref): 0
Last Update: 6 days ago
- CrossRef: 0
Last Update: 5 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):